Ablative Solutions: Funding, Investors & Team (Oct 2026)
Ablative Solutions is a clinical gadget firm that offers an option in contrast to careful renal denervation for treating hypertension. Its innovation includes endovascular catheters to give a solid, sturdy, practical, and safe option in contrast to careful renal denervation for the treatment of hypertension and different illnesses brought about by an overactive thoughtful sensory system. The organization was established in 2011 by Tim Fischell, MD, FACC, and David Fischell, Ph.D., to address this huge neglected clinical need.
Ablative Solutions has raised $91.4M across 1 funding round on record, the most recent a Series D of $91.4M announced in Jun 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ablative Solutions Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Ablative Solutions Funding Rounds
Ablative Solutions Founders and Leadership Team
No contact details are on record for this team yet.
Ablative Solutions Funding Compared to Other Biotechnology Startups
Ablative Solutions' latest round of $91.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ablative Solutions in Biotechnology and San Jose
Companies Similar to Ablative Solutions
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Ablative Solutions Funding FAQs
What does Ablative Solutions do?
Ablative Solutions is a clinical gadget firm that offers an option in contrast to careful renal denervation for treating hypertension. Its innovation includes endovascular catheters to give a solid, sturdy, practical, and safe option in contrast to careful renal denervation for the treatment of hypertension and different illnesses brought about by an overactive thoughtful sensory system. The organization was established in 2011 by Tim Fischell, MD, FACC, and David Fischell, Ph.D., to address this huge neglected clinical need.
How much funding has Ablative Solutions raised?
Ablative Solutions has raised $91.4M across 1 round on record. The most recent is a Series D of $91.4M announced in Jun 2022.
When did Ablative Solutions last raise funding?
Ablative Solutions' most recent funding round on record is a Series D of $91.4M, announced in Jun 2022.
Who founded Ablative Solutions?
FundedIQ lists David Fischell (Founder) at Ablative Solutions.
Where is Ablative Solutions headquartered?
Ablative Solutions is based in San Jose, California, United States.
How many employees does Ablative Solutions have?
Ablative Solutions is in the 11-50 employee band.
How does Ablative Solutions' funding compare to other Biotechnology startups?
Ablative Solutions' latest round of $91.4M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Ablative Solutions Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ablative Solutions is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.